Molecular structure of SKL2001, CAS Number: 909089-13-0
SKL2001 (CAS 909089-13-0)
Alternate Names:
5-(2-furanyl)-N-[3-(1H-imidazol-1-yl)propyl]-3-isoxazolecarboxamide
CAS Number:
909089-13-0
Molecular Weight:
286.3
Molecular Formula:
C14H14N4O3
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
SKL2001 (CAS 909089-13-0) References
- SKL2001 suppresses colon cancer spheroid growth through regulation of the E-cadherin/β-Catenin complex. | Ohashi, W., et al. 2017. Biochem Biophys Res Commun. 493: 1342-1348. PMID: 28970068
- Role of Wnt/β-catenin pathway agonist SKL2001 in Caerulein-induced acute pancreatitis. | Huang, HL., et al. 2019. Can J Physiol Pharmacol. 97: 15-22. PMID: 30326193
- The Osteocyte Stimulated by Wnt Agonist SKL2001 Is a Safe Osteogenic Niche Improving Bioactivities in a Polycaprolactone and Cell Integrated 3D Module. | Liu, Y., et al. 2022. Cells. 11: PMID: 35269452
- Differentiation of Human Wharton's Jelly Mesenchymal Stem Cells into SOX17 Expressing Cells Using a Wnt/ß-catenin Pathway Agonist on Polylactic Acid/Chitosan Nanocomposite Scaffold. | Hoveizi, E. and Tavakol, SH. 2022. Cell J. 24: 55-61. PMID: 35279960
- Fatty acid-binding protein 5 aggravates pulmonary artery fibrosis in pulmonary hypertension secondary to left heart disease via activating wnt/β-catenin pathway. | Lei, Q., et al. 2022. J Adv Res. 40: 197-206. PMID: 36100327
- BMAL1 regulates osteoblast differentiation through mTOR/GSK3β/β-catenin pathway. | Li, H., et al. 2023. J Mol Endocrinol. 70: PMID: 36942818
- Downregulation of MAL2 inhibits breast cancer progression through regulating β-catenin/c-Myc axis. | An, L., et al. 2023. Cancer Cell Int. 23: 144. PMID: 37480012
- Sevoflurane inhibits cholangiocarcinoma via Wnt/β-catenin signaling pathway. | Cheng, H. and Li, Q. 2023. BMC Gastroenterol. 23: 279. PMID: 37568083
- Circ-CCT2 Activates Wnt/β-catenin Signaling to Facilitate Hepatoblastoma Development by Stabilizing PTBP1 mRNA. | Zhu, Q., et al. 2024. Cell Mol Gastroenterol Hepatol. 17: 175-197. PMID: 37866478
- Bufalin targeting CAMKK2 inhibits the occurrence and development of intrahepatic cholangiocarcinoma through Wnt/β-catenin signal pathway. | Zhang, H., et al. 2023. J Transl Med. 21: 900. PMID: 38082327
Activator of:
AIDA, ANKRD36–Ankrd36, Armadillo (β-catenin), CLLD6, Conductin, Dapper1, Diversin, Dkk-2, Dvl-1, Dvl-3, FRAT2, frizzled-3, frizzled-7, GPR177, HEXDC, LEF-1, LGR6, LRP6, Manic Fringe, NKD2, R-Spondin, R-Spondin4, Six2, Six3, TCF-1, TMEM170, Wingless, Wnt-1, Wnt-15, Wnt-16, Wnt-2b, Wnt-5b, Wnt-6, and Wnt-8b.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
SKL2001, 10 mg | sc-507410 | 10 mg | $123.00 |